Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 0 | ||||
Sells | 1 | -25K | 100% | $1.33 | -$33.3K |
Net | -1 | -25K | -100% | -$33.3K |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Reprogrammed Interchange LLC | 10%+ Owner | $48.7M | Dec 30, 2024 | ||
Ra Capital Management, L.P. | Director, 10%+ Owner | $32.5M | Dec 30, 2024 | ||
5AM Ventures VI, L.P. | 10%+ Owner | $3.22M | Nov 16, 2021 | ||
Robert Ang | PRESIDENT AND CEO, Director | $677K | Nov 6, 2024 | ||
Nathan D. Jorgensen | Chief Financial Officer | $331K | May 6, 2024 | ||
Tirtha Chakraborty | Chief Scientific Officer | $146K | Nov 6, 2024 | ||
Eyal C. Attar | Chief Medical Officer | $102K | -$33.3K | -24.6% | Dec 27, 2024 |
Amy Quinlan | Vice President of Finance | $43.3K | Nov 6, 2024 | ||
Fouad Namouni | Director | May 23, 2024 | |||
Daniella Beckman | Director | May 23, 2024 | |||
Christopher Slapak | Chief Medical Officer | Feb 1, 2022 | |||
Matthew R. Patterson | Director | May 23, 2024 | |||
Joshua Resnick | Director | May 23, 2024 | |||
Han Wook Choi | Chief Financial Officer | Sep 30, 2024 | |||
Erez Kalir | Director | Jan 6, 2025 | |||
David Lubner | Director | May 23, 2024 | |||
Sven Ante Lundberg | Director | May 23, 2024 | |||
Kush Parmar | Director, 10%+ Owner | Jun 14, 2022 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|